Fritextsökning
Innehållstyper
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Bioreactor features disposable sensors
The Biostat Cultibag STR line of bioreactors from Sartorius-Stedim features disposable components to reduce risk of contamination.
-
New partnering platform
EBD Group's Partnering One is the new partnering platform for Biotech Forum 2009.
-
Så ska USA satsa på life science
I president Obamas budgetförslag för år 2016 nämns bland annat en satsning mot spridningen av antibiotikaresistens och ett initiativ för individanpassad medicin.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
BMAs: Run your own business
After graduation you must decide: be an employee or start your own business. This is not really the situation for BMAs today, but a collaborative project betwee...
-
Pronova Biopharma grows
Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark
-
Mathematician new dean at DTU
On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.
-
Gates satsar på Crispr
Microsoft-grundaren finansierar genterapibolaget Editas Medicine.
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
Norwegian describes scrapie gene
Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.
-
Esteya får grönt ljus i USA
Elektas nya behandlingssystem för behandling av hudcancer får klartecken att lanseras på den amerikanska marknaden.
-
Satsar på modifierade antikroppar
Antikroppskonjugat är en av nästa generations antikroppstekniker. De kan användas för en målinriktad behandling, exempelvis vid cancer.
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Happy exhibitors!
There were fewer vistors this year but most exhibitors are content.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Siemens och Raysearch gör slut
Medicinteknikbolagen Raysearch laboratories och Siemens Healthcare har beslutat att avsluta sitt samarbete.
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
KI i open innovation-samarbete
Genom projektet Ultra-DD ska tidig läkemedelsutveckling bli mer effektiv.
BREAKING